MediciNova Other Stockholder Equity from 2010 to 2024
| MNOV Stock | USD 2.05 0.08 3.76% |
Other Stockholder Equity | First Reported 2004-09-30 | Previous Quarter 478.6 M | Current Value 479.1 B | Quarterly Volatility 53.2 B |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Other Stockholder Equity |
Latest MediciNova's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of MediciNova over the last few years. It is MediciNova's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
MediciNova Other Stockholder Equity Regression Statistics
| Arithmetic Mean | 365,186,193 | |
| Geometric Mean | 302,193,357 | |
| Coefficient Of Variation | 32.10 | |
| Mean Deviation | 77,844,217 | |
| Median | 364,886,468 | |
| Standard Deviation | 117,226,109 | |
| Sample Variance | 13742T | |
| Range | 468.1M | |
| R-Value | 0.72 | |
| Mean Square Error | 7063.6T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 18,951,174 | |
| Total Sum of Squares | 192387.4T |
MediciNova Other Stockholder Equity History
About MediciNova Financial Statements
MediciNova investors use historical fundamental indicators, such as MediciNova's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 478.1 M | 331 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.